Kinetic Resolution Simulator

In a kinetic resolution the two enantiomers of the racemate react as competing irreversible pseudo-first-order pathways with rate constants k_fast and k_slow. The enantiomeric ratio is simply their quotient: E = k_fast / k_slow Because absolute rate constants are rarely known during a real experiment, Chen et al. (J. Am. Chem. Soc. 1982, 104, 7294–7299) derived closed-form expressions relating E to two quantities that ARE routinely measured by chiral HPLC or GC — the conversion c and the enantiomeric excess of either the remaining substrate (ee_s) or the newly formed product (ee_p): E = ln[(1-c)(1-ee_s)] / ln[(1-c)(1+ee_s)] E = ln[1-c(1+ee_p)] / ln[1-c(1-ee_p)] This simulator integrates the underlying kinetics directly — each enantiomer decays as its own exponential, c_R(t)=1-exp(-k_R·t) and c_S(t)=1-exp(-k_S·t) with k_R = E·k_S — and the resulting c, ee_s and ee_p trajectories satisfy the Chen–Sih equations exactly at every timepoint, so the live readout you see is not a cartoon approximation but the real solved kinetics. Practically: E < 15 gives poor, commercially useless resolution; E = 15–30 is usable but requires stopping the reaction precisely near c≈0.5; E > 200 is regarded as "enzymatically perfect" — both the remaining substrate and the product reach >99% ee over a wide conversion window, which is exactly what CAL-B achieves with many secondary benzylic alcohols such as 1-phenylethanol.

Candida antarctica Lipase B is a ~33 kDa α/β-hydrolase (Uppenberg et al., Structure 1994) with a classical Ser105–Asp187–His224 catalytic triad and an oxyanion hole formed by backbone NH groups of Thr40 and Gln106. Unlike Lipase A or porcine pancreatic lipase, CAL-B has only a very small, poorly defined "lid" helix, so it shows little to no interfacial activation — it works efficiently even in the absence of a lipid-water interface, which is exactly why it tolerates neat (solvent-free) organic media so well. Its active site is a narrow, funnel-shaped hydrophobic pocket that accommodates the medium-sized substituent of a secondary alcohol on one side and a small substituent on the other. This steric asymmetry is the physical origin of E: for 1-phenylethanol-type substrates the enzyme reacts roughly 100–500× faster with the (R)-enantiomer than the (S)-enantiomer, following the empirical "Kazlauskas rule" for secondary alcohol facial selectivity. Commercially the enzyme is sold immobilized as Novozym 435 (Novozymes A/S): CAL-B physically adsorbed onto a macroporous poly(methyl methacrylate) acrylic resin (Lewatit VP OC 1600), particle size roughly 315–1000 µm, with a protein loading around 1–10% w/w of the carrier. Immobilization boosts operational stability, allows simple filtration/recovery between batches, and can even enhance enantioselectivity relative to the free enzyme in solution.

Lipase kinetic resolution is one of the most mature applications of biocatalysis in fine-chemical and pharmaceutical manufacturing: • BASF ChiPros® process — BASF operates large-scale lipase-catalyzed kinetic resolutions of racemic chiral amines (e.g. 1-phenylethylamine and related building blocks) using an acyl donor in continuous enzyme-membrane reactors, producing multi-tonne quantities of single-enantiomer amine intermediates for agrochemicals and pharmaceuticals — one of the first lipase processes run at industrial scale. • Ibuprofen ester resolution — racemic ibuprofen (only the (S)-enantiomer is pharmacologically active as a COX inhibitor) can be resolved via lipase-catalyzed esterification/hydrolysis of its esters, avoiding the wasteful chiral-pool synthesis routes used historically. • Secondary alcohol pharma intermediates — CAL-B-mediated transesterification of racemic secondary alcohols (e.g. building blocks en route to HIV-protease inhibitors, beta-blockers, and antifungal azoles) with vinyl acetate is a standard medicinal-chemistry-scale resolution, prized because vinyl acetate's byproduct (acetaldehyde) simply evaporates, driving the equilibrium irreversibly forward with no need for excess reagent recycling. Anderson, Larsson & Kirk's widely cited review ("One Biocatalyst – Many Applications," Biocatalysis and Biotransformation 1998, 16, 181–204) catalogued hundreds of such CAL-B resolutions across alcohols, amines, and carboxylic acids, cementing Novozym 435 as the default lipase screened first in industrial route-scouting.

• Solvent-free (neat) operation — with a liquid or low-melting substrate and vinyl acetate as both reagent and reaction medium, Novozym 435 runs with no organic solvent at all, simplifying downstream purification and improving the E-factor of the process. • Temperature optimum ≈ 40–60 °C — below ~30 °C reaction rates are impractically slow for production scale; above ~65–70 °C the adsorbed enzyme begins to denature/desorb from the acrylic resin, and selectivity typically erodes because the less-favored enantiomer's transition state becomes proportionally more accessible (E decreases with rising T, consistent with the Eyring/Arrhenius temperature dependence of ΔΔG‡ between the two enantiomeric pathways). • Water activity control — lipases need a thin hydration shell (aw ≈ 0.2–0.4) to remain catalytically competent even in "anhydrous" organic media; too much water reverses the reaction toward hydrolysis and erodes the irreversibility that vinyl acetate provides. • Reuse / operational stability — because Novozym 435 is a solid, filterable catalyst, it is routinely recovered and reused for 10–15 batch cycles (sometimes far more in continuous packed-bed reactors) with under 10% loss of activity, which is what makes it economically viable at multi-kilogram to multi-tonne scale despite the enzyme's per-kilogram cost.

Classical kinetic resolution can never exceed 50% yield of a single enantiomer, because the slow-reacting enantiomer is a spectator that simply accumulates unconverted — at c=0.5 exactly half the racemate remains as substrate and half has become product, and pushing conversion further only sacrifices product ee to consume more of the slow enantiomer. Dynamic Kinetic Resolution (DKR) removes this ceiling by continuously racemizing the slow-reacting (unwanted) substrate enantiomer in situ, feeding it back into the fast-reacting pool so that, in principle, 100% of the racemate can be converted to a single enantiomer product. The classic combination pairs CAL-B with a ruthenium racemization catalyst — most famously Shvo's catalyst or Bäckvall's indenyl-Ru systems — which reversibly dehydrogenates/rehydrogenates the alcohol's stereocenter via a transient ketone intermediate, racemizing it without touching the already-formed, configurationally stable ester product. Verho & Bäckvall's review (J. Am. Chem. Soc. 2015, 137, 3996–4009) and the broader Bäckvall/Martín-Matute body of work document DKR yields routinely exceeding 90% with >99% ee for a wide range of secondary alcohols and amines, at the cost of a more complex bimetallic/enzyme catalyst system and typically higher operating temperatures (~70–90 °C) to keep the Ru racemization fast relative to the lipase acylation. Toggle the E-value slider above to 200 and watch the simulator's conversion curve plateau near 50% — that plateau is precisely the constraint DKR is designed to escape.